Richard J. Broadmore

Author

Also Known As

R. J. Broadmore, Richard Broadmore, Richard J Broadmore, Richard J. Broadmore

Publications

124

Citations

H-Index

Concepts

All Affiliations

Richard J. Broadmore is an author at Eli Lilly (United Kingdom) specializing in pharmacology, medicine, and drug discovery.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	113
2	Health Sciences	1	1	37
3	Biomolecular Engineering	1	1	16
4	Neuroscience	1	1	37
5	Pathology	1	1	14

Richard J. Broadmore

Publications

113

Citations

H-Index

Page 1

	Year	Citations
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig Ian A. Pullar, John R. Boot, Richard J. Broadmore, European Journal of Pharmacology Molecular PhysiologyNeurophysiologyMedicineFunctional SelectivityPhysiology	2004	37
PSAB-OFP, a selective α7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor Lisa M. Broad, Catherine Felthouse, Ruud Zwart, European Journal of Pharmacology 5-Ht3 ReceptorMolecular PharmacologyMedicineNicotinePhysiology	2002	30
Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity: chemistry and pharmacological evaluation of a series of thienopyran derivatives Alicia Torrado, Carlos José Einicker Lamas, Javier Agejas, Bioorganic & Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryMedicinePharmacological AgentPharmacotherapy	2004	16
SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis Graham H. Timms, John R. Boot, Richard J. Broadmore, Bioorganic & Medicinal Chemistry Letters Sar DevelopmentInhibitor LeadFunctional SelectivityMedicineDrug Discovery	2004	16
Anin vivo investigation of the effect of anthraquinones on the turnover of aggrecans in spontaneous osteoarthritis in the guinea pig Stephen Carney, C A Hicks, B. Tree, Inflammation Research InflammationAnti-inflammatoryMusculoskeletal ResearchMedicineSpontaneous Osteoarthritis	1995	14

Page 1